220 related articles for article (PubMed ID: 21644815)
1. Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation.
Schäfer A; Pahnke A; Schaffert D; van Weerden WM; de Ridder CM; Rödl W; Vetter A; Spitzweg C; Kraaij R; Wagner E; Ogris M
Hum Gene Ther; 2011 Dec; 22(12):1463-73. PubMed ID: 21644815
[TBL] [Abstract][Full Text] [Related]
2. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors.
Abourbeh G; Shir A; Mishani E; Ogris M; Rödl W; Wagner E; Levitzki A
IUBMB Life; 2012 Apr; 64(4):324-30. PubMed ID: 22362419
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
Klutz K; Schaffert D; Willhauck MJ; Grünwald GK; Haase R; Wunderlich N; Zach C; Gildehaus FJ; Senekowitsch-Schmidtke R; Göke B; Wagner E; Ogris M; Spitzweg C
Mol Ther; 2011 Apr; 19(4):676-85. PubMed ID: 21245850
[TBL] [Abstract][Full Text] [Related]
4. Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery.
Decker S; Taschauer A; Geppl E; Pirhofer V; Schauer M; Pöschl S; Kopp F; Richter L; Ecker GF; Sami H; Ogris M
Eur J Pharm Biopharm; 2022 Jul; 176():211-221. PubMed ID: 35584718
[TBL] [Abstract][Full Text] [Related]
5. Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Willhauck MJ; Dohmen C; Wunderlich N; Knoop K; Zach C; Senekowitsch-Schmidtke R; Gildehaus FJ; Ziegler S; Fürst S; Göke B; Wagner E; Ogris M; Spitzweg C
Hum Gene Ther; 2011 Dec; 22(12):1563-74. PubMed ID: 21851208
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics.
Li Z; Zhao R; Wu X; Sun Y; Yao M; Li J; Xu Y; Gu J
FASEB J; 2005 Dec; 19(14):1978-85. PubMed ID: 16319141
[TBL] [Abstract][Full Text] [Related]
7. Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes.
Kloeckner J; Prasmickaite L; Høgset A; Berg K; Wagner E
J Drug Target; 2004 May; 12(4):205-13. PubMed ID: 15506169
[TBL] [Abstract][Full Text] [Related]
8. Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier.
Schaffert D; Kiss M; Rödl W; Shir A; Levitzki A; Ogris M; Wagner E
Pharm Res; 2011 Apr; 28(4):731-41. PubMed ID: 20694527
[TBL] [Abstract][Full Text] [Related]
9. Photochemical enhancement of DNA delivery by EGF receptor targeted polyplexes.
Bonsted A; Wagner E; Prasmickaite L; Høgset A; Berg K
Methods Mol Biol; 2008; 434():171-81. PubMed ID: 18470645
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery.
Steinborn B; Truebenbach I; Morys S; Lächelt U; Wagner E; Zhang W
J Gene Med; 2018 Jul; 20(7-8):e3041. PubMed ID: 29949222
[TBL] [Abstract][Full Text] [Related]
11. Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.
Urnauer S; Klutz K; Grünwald GK; Morys S; Schwenk N; Zach C; Gildehaus FJ; Rödl W; Ogris M; Wagner E; Spitzweg C
J Gene Med; 2017 May; 19(5):. PubMed ID: 28423213
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.
Urnauer S; Schmohl KA; Tutter M; Schug C; Schwenk N; Morys S; Ziegler S; Bartenstein P; Clevert DA; Wagner E; Spitzweg C
Gene Ther; 2019 Apr; 26(3-4):93-108. PubMed ID: 30683895
[TBL] [Abstract][Full Text] [Related]
13. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor-targeted gene delivery by bioreducible polyethylenimine tethering EGFR divalent ligands.
Lee D; Lee YM; Kim J; Lee MK; Kim WJ
Biomater Sci; 2015 Jul; 3(7):1096-104. PubMed ID: 26221943
[TBL] [Abstract][Full Text] [Related]
15. Cryoconserved shielded and EGF receptor targeted DNA polyplexes: cellular mechanisms.
von Gersdorff K; Ogris M; Wagner E
Eur J Pharm Biopharm; 2005 Jul; 60(2):279-85. PubMed ID: 15939238
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
Li D; Wang QQ; Tang GP; Huang HL; Shen FP; Li JZ; Yu H
J Zhejiang Univ Sci B; 2006 Nov; 7(11):906-11. PubMed ID: 17048306
[TBL] [Abstract][Full Text] [Related]
17. Peptide GE11-Polyethylene Glycol-Polyethylenimine for targeted gene delivery in laryngeal cancer.
Ren H; Zhou L; Liu M; Lu W; Gao C
Med Oncol; 2015 Jul; 32(7):185. PubMed ID: 26008151
[TBL] [Abstract][Full Text] [Related]
18. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.
Hailing T; Yonghong P; Yufeng Z; Haitao T
J Control Release; 2022 Sep; 349():592-605. PubMed ID: 35872181
[TBL] [Abstract][Full Text] [Related]
19. Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding.
Fella C; Walker GF; Ogris M; Wagner E
Eur J Pharm Sci; 2008 Aug; 34(4-5):309-20. PubMed ID: 18586470
[TBL] [Abstract][Full Text] [Related]
20. Double Click-Functionalized siRNA Polyplexes for Gene Silencing in Epidermal Growth Factor Receptor-Positive Tumor Cells.
Wang Y; Luo J; Truebenbach I; Reinhard S; Klein PM; Höhn M; Kern S; Morys S; Loy DM; Wagner E; Zhang W
ACS Biomater Sci Eng; 2020 Feb; 6(2):1074-1089. PubMed ID: 33464867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]